BioSpace News Archive

Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, announced today that it has sold all remaining common shares of South Korea -based Telcon RF Pharmaceutical Inc. (KOSDAQ: 200230) in accordance with the Telcon agreement reported by Emmaus in its Current Report on Form 8-K fi

Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signaling pathways, including the endocannabinoid system, today announced the closing of an underwritten public offering of units for gross proceeds of approximately $7.6 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additio

Lumentum Holdings Inc. (“Lumentum”) today announced that it will release its fiscal first quarter 2021 financial results for the period ended September 26, 2020, on Monday, November 2, 2020, before the market opens.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a new organizational and leadership structure for its global commercial operations as well as its product and services organization,

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and its partner PharmaMar (MSE: PHM) today announced they will present new data for Zepzelca™ (lurbinectedin) in small cell lung cancer (SCLC) at the International Association for the Study of Lung Cancer (IASLC) 2020 North America Conference

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that Goldman Sachs (NYSE:GS) is recognizing Anthony Johnson, M.D., Goldfinch Bio’s President and Chief Exec

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In this role, Ms. Reiter will drive new business opportunities at Calyxt to support the company’s recently announced go-to-market strategies.

The Lewy Body Dementia Association and Acadia Pharmaceuticals Inc. announced an exclusive partnership on the production and release of a disease education adaptation of the new film Robin’s Wish©, a documentary detailing the late actor Robin Williams’ courageous battle with the neurodegenerative disorder, Lewy body dementia.

BioNJ announced the winners of its 2020 Company and Pitch Presentation Competition held in conjunction with the organization’s 10th Annual BioPartnering Conference held virtually last Tuesday, October 6, and Wednesday, October 7.

Quest Analytics today announced that Barbara Dumery will join the leadership team as Chief Product Officer